Model DetailsEye - Harderian gland cystadenoma

Model Name

Eye - Harderian gland cystadenoma

Strain

(C57BL/6 x C3H)F1

Tumor Inducing Agent(s)

Chemical/Drug : ethylene oxide

Tumor Synonym

harderian gland papillary cystadenoma

Strain Synonyms

B6C3F1  •  (C57BL/6xC3H)  •  F1-hybrid B6C3F1  •  B6C3F1  •  hybrid B6C3F1  •  B6C3F1 (C3H x C57B16)  •  B6C3F1 hybrid
Organ Affected Sex Frequency Age Of Detection Additional Information Expand all Collapse all Reference
Eye - Harderian gland Male

20.45%

(9 of 44 mice)
2 years
  • Treatment Notes
  • Notes

    Reproductive Status: reproductive status not specified

Hong HH, Toxicol Pathol 2007;35(1):81-5
Eye - Harderian gland Male

19.05%

(8 of 42 mice)
2 years
  • Treatment Notes
  • Notes

    Reproductive Status: reproductive status not specified

Hong HH, Toxicol Pathol 2007;35(1):81-5
Eye - Harderian gland Female

13.04%

(6 of 46 mice)
2 years
  • Treatment Notes
  • Notes

    Reproductive Status: reproductive status not specified

Hong HH, Toxicol Pathol 2007;35(1):81-5
Eye - Harderian gland Female

17.02%

(8 of 47 mice)
2 years
  • Treatment Notes
  • Notes

    Reproductive Status: reproductive status not specified

Hong HH, Toxicol Pathol 2007;35(1):81-5
Eye - Harderian gland Mixed Population

16.67%

(15 of 90 mice)
2 years
  • Treatment Notes
  • Notes

    Reproductive Status: reproductive status not specified

Hong HH, Toxicol Pathol 2007;35(1):81-5
Eye - Harderian gland Mixed Population

17.98%

(16 of 89 mice)
2 years
  • Treatment Notes
  • Notes

    Reproductive Status: reproductive status not specified

Hong HH, Toxicol Pathol 2007;35(1):81-5